SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 92.02 |
| Enterprise Value ($M) | 44.53 |
| Book Value ($M) | 150.91 |
| Book Value / Share | 3.04 |
| Price / Book | 0.61 |
| NCAV ($M) | 137.80 |
| NCAV / Share | 2.78 |
| Price / NCAV | 0.67 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.61 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 25.32 |
| Current Ratio | 25.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 165.71 |
| Assets | 178.82 |
| Liabilities | 27.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -106.96 |
| Net Income | -147.27 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -108.79 |
| Cash from Investing | 58.40 |
| Cash from Financing | -11.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Tang Capital Management Llc | 9.80 | ||
| 13G/A | Flynn James E | 3.78 | -52.98 | |
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G | Tang Capital Partners Lp | 9.50 | ||
| 13D/A | Frazier Life Sciences Public Fund, L.P. | 21.40 | 8.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 26,077 | 201,911 | 12.92 | |
| 14,352 | 75,656 | 18.97 | |
| 28,398 | 94,566 | 30.03 | |
| 19,503 | 77,273 | 25.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GLUE – Monte Rosa Therapeutics, Inc. | GOSS – Gossamer Bio, Inc. |
| HALO – Halozyme Therapeutics, Inc. | HOWL – Werewolf Therapeutics, Inc. |
| HUMA – Humacyte, Inc. |
Financial data and stock pages provided by
Fintel.io